| |
| |
|
| Insider
Information: |
Mclaughlin Kevin F |
| Relationship: |
Director |
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
11,900 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$577,507 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
11,900 |
|
|
| Total
Value |
$577,507 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acceleron Pharma Inc |
XLRN |
SVP, CFO and Treasurer |
2021-11-19 |
0 |
2014-05-19 |
0 |
Premium* |
|
|
Vericel Corp |
VCEL |
|
2024-05-01 |
11,900 |
2020-04-29 |
0 |
Premium* |
|
|
Decibel Therapeutics, Inc. |
DBTX |
Director |
2023-09-25 |
0 |
2023-06-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
101 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2015-09-09 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
80,000 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2016-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,100 |
92,600 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2017-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,900 |
77,800 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,138 |
47,939 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2019-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,700 |
42,927 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2020-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,369 |
11,216 |
0 |
- |
|
| VCEL |
Vericel Corp |
|
– • – |
2020-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,750 |
1,750 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2021-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
4,868 |
10,681 |
0 |
- |
|
| VCEL |
Vericel Corp |
|
– • – |
2021-04-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,750 |
3,500 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2021-11-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,681) |
0 |
0 |
- |
|
| VCEL |
Vericel Corp |
|
– • – |
2022-04-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,600 |
6,100 |
0 |
- |
|
| VCEL |
Vericel Corp |
|
• • – |
2023-04-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,600 |
8,700 |
0 |
- |
|
| DBTX |
Decibel Therapeutics, Inc... |
|
• • – |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| DBTX |
Decibel Therapeutics, Inc... |
Director |
– • – |
2023-09-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,000) |
0 |
0 |
- |
|
| VCEL |
Vericel Corp |
|
• • – |
2024-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,200 |
11,900 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2016-05-23 |
4 |
OE |
$5.28 |
$1,584 |
D/D |
300 |
92,900 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2015-01-12 |
4 |
OE |
$3.88 |
$7,760 |
D/D |
2,000 |
27,000 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2014-09-08 |
4 |
OE |
$3.88 |
$12,804 |
D/D |
3,300 |
3,300 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2020-12-10 |
4 |
OE |
$27.97 |
$16,792 |
D/D |
500 |
11,716 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2015-01-07 |
4 |
OE |
$3.88 |
$19,400 |
D/D |
5,000 |
30,000 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2015-06-10 |
4 |
OE |
$3.88 |
$19,400 |
D/D |
5,000 |
35,000 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2015-07-28 |
4 |
OE |
$3.88 |
$19,400 |
D/D |
5,000 |
40,000 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2016-07-07 |
4 |
OE |
$3.88 |
$19,400 |
D/D |
5,000 |
62,600 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2015-02-09 |
4 |
OE |
$3.88 |
$25,220 |
D/D |
6,500 |
26,500 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2015-03-09 |
4 |
OE |
$3.88 |
$25,220 |
D/D |
6,500 |
26,500 |
0 |
- |
|
101 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
